BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26039674)

  • 1. Comparative genomic analysis of Brucella abortus vaccine strain 104M reveals a set of candidate genes associated with its virulence attenuation.
    Yu D; Hui Y; Zai X; Xu J; Liang L; Wang B; Yue J; Li S
    Virulence; 2015; 6(8):745-54. PubMed ID: 26039674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid minor groove binder PCR method for distinguishing the vaccine strain Brucella abortus 104M.
    Nan W; Qin L; Wang Y; Zhang Y; Tan P; Chen Y; Mao K; Chen Y
    BMC Vet Res; 2018 Jan; 14(1):27. PubMed ID: 29361960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome sequences of three live attenuated vaccine strains of Brucella species and implications for pathogenesis and differential diagnosis.
    Wang Y; Ke Y; Wang Z; Yuan X; Qiu Y; Zhen Q; Xu J; Li T; Wang D; Huang L; Chen Z
    J Bacteriol; 2012 Nov; 194(21):6012-3. PubMed ID: 23045513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic analysis between newly sequenced Brucella abortus vaccine strain A19 and another Brucella abortus vaccine S19.
    Wang S; Wang W; Sun K; Bateer H; Zhao X
    Genomics; 2020 Mar; 112(2):1444-1453. PubMed ID: 31454518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Genome Sequence of Brucella abortus vaccine strain A19 provides insights on its virulence attenuation compared to Brucella abortus strain 9-941.
    Wang S; Zhao X; Sun K; Bateer H; Wang W
    Gene; 2022 Jul; 830():146521. PubMed ID: 35447245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.
    Yang X; Thornburg T; Walters N; Pascual DW
    Vaccine; 2010 Jan; 28(4):1069-74. PubMed ID: 19914192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.
    Truong QL; Cho Y; Park S; Kim K; Hahn TW
    Vaccine; 2016 Jan; 34(2):237-244. PubMed ID: 26616550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice.
    Trant CG; Lacerda TL; Carvalho NB; Azevedo V; Rosinha GM; Salcedo SP; Gorvel JP; Oliveira SC
    Infect Immun; 2010 May; 78(5):2283-91. PubMed ID: 20194591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes.
    Crasta OR; Folkerts O; Fei Z; Mane SP; Evans C; Martino-Catt S; Bricker B; Yu G; Du L; Sobral BW
    PLoS One; 2008 May; 3(5):e2193. PubMed ID: 18478107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Brucella melitensis Rev.1 vaccine-strain genetic markers: Towards understanding the molecular mechanism behind virulence attenuation.
    Issa MN; Ashhab Y
    Vaccine; 2016 Sep; 34(41):4884-4891. PubMed ID: 27595444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic analysis of the original Elberg Brucella melitensis Rev.1 vaccine strain reveals insights into virulence attenuation.
    Salmon-Divon M; Yeheskel A; Kornspan D
    Virulence; 2018; 9(1):1436-1448. PubMed ID: 30139304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Brucella abortus S19 vaccines commercialized in Brazil: immunogenicity, residual virulence and MLVA15 genotyping.
    Miranda KL; Poester FP; Minharro S; Dorneles EM; Stynen AP; Lage AP
    Vaccine; 2013 Jun; 31(29):3014-8. PubMed ID: 23664986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.
    Yang X; Clapp B; Thornburg T; Hoffman C; Pascual DW
    Vaccine; 2016 Oct; 34(44):5290-5297. PubMed ID: 27639282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice.
    Rosinha GM; Freitas DA; Miyoshi A; Azevedo V; Campos E; Cravero SL; Rossetti O; Splitter G; Oliveira SC
    Infect Immun; 2002 Sep; 70(9):5036-44. PubMed ID: 12183550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the vacB gene in the pathogenesis of Brucella abortus.
    Miyoshi A; Rosinha GM; Camargo IL; Trant CM; Cardoso FC; Azevedo V; Oliveira SC
    Microbes Infect; 2007 Mar; 9(3):375-81. PubMed ID: 17306588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel drug targets for humans and potential vaccine targets for cattle by subtractive genomic analysis of Brucella abortus strain 2308.
    Mahmud A; Khan MT; Iqbal A
    Microb Pathog; 2019 Dec; 137():103731. PubMed ID: 31509762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice.
    Lacerda TL; Cardoso PG; Augusto de Almeida L; Camargo IL; Afonso DA; Trant CC; Macedo GC; Campos E; Cravero SL; Salcedo SP; Gorvel JP; Oliveira SC
    Vaccine; 2010 Aug; 28(34):5627-34. PubMed ID: 20580469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.